William Snider - 17 Dec 2025 Form 3 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Director
Signature
/s/ William Snider
Issuer symbol
HBIO
Transactions as of
17 Dec 2025
Net transactions value
$0
Form type
3
Filing time
30 Dec 2025, 20:46:35 UTC
Previous filing
07 Jun 2023

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Snider William Director C/O HARVARD BIOSCIENCE, INC., 84 OCTOBER HILL ROAD, HOLLISTON /s/ William Snider 30 Dec 2025 0001340831

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HBIO Warrant (right to buy) 17 Dec 2025 Common Stock 150,000 $0.5000 As manager F1, F3
holding HBIO Warrant (right to buy) 17 Dec 2025 Common Stock 600,000 $0.5000 As manager F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by BroadOak Fund VI, L.P. The reporting person is the Manager of BroadOak Fund VI, L.P. The reporting person disclaims beneficial ownership of the securities held by BroadOak Fund VI, L.P except to the extent of his pecuniary interest therein, if any.
F2 Held by BroadOak Income Fund, L.P. The reporting person is the Manager of BroadOak Income Fund, L.P. The reporting person disclaims beneficial ownership of the securities held by BroadOak Income Fund, L.P except to the extent of his pecuniary interest therein, if any.
F3 The Warrants are exercisable immediately. Notwithstanding the foregoing, the Reporting Person shall not be entitled to exercise the Warrants to the extent that such exercise would cause the aggregate number of shares of common stock of the Issuer, $0.01 par value per share (the "Common Stock"), beneficially owned by the Reporting Person to exceed 19.99% of the total number of outstanding shares of Common Stock following such exercise.

Remarks:

Exhibit 24 - Power of Attorney